- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Lack of; Attention, With Hyperactivity (ADHD) in United States
Total 575 results
-
Ironshore Pharmaceuticals and Development, IncCompletedAttention Deficit Hyperactivity DisorderUnited States
-
Eli Lilly and CompanyCompletedAttention Deficit Hyperactivity DisorderCanada, United States
-
Eli Lilly and CompanyCompletedAttention Deficit Hyperactivity DisorderUnited Kingdom
-
Novartis PharmaceuticalsCompletedAttention Deficit/Hyperactivity DisorderGermany, United States, Belgium, Colombia, Denmark, Sweden
-
ShireCompletedAttention-deficit/Hyperactivity DisorderUnited States, Canada, Germany, Hungary, Sweden
-
ShireCompletedAttention-deficit/Hyperactivity DisorderSpain, Belgium, United States, Netherlands, United Kingdom, Italy, Germany, Canada, France, Sweden
-
Massachusetts General HospitalCompletedAutism Spectrum Disorder | Attention-deficit/Hyperactivity DisorderUnited States
-
Children's Hospital of PhiladelphiaUniversity of Pennsylvania; U.S. Department of Education; Rutgers UniversityRecruitingAttention Deficit Hyperactivity Disorder | Executive DysfunctionUnited States
-
Aevi Genomic Medicine, LLC, a Cerecor companyCompletedAttention Deficit Disorder With HyperactivityUnited States
-
New River PharmaceuticalsCompletedSubstance-Related Disorders | Attention Deficit Disorder With Hyperactivity | Amphetamine-Related DisordersUnited States
-
PfizerCompletedAttention Deficit Hyperactivity DisorderUnited States
-
PfizerCompletedAttention Deficit Hyperactivity DisorderUnited States
-
PfizerCompletedAttention Deficit Hyperactivity DisorderUnited States
-
Novartis PharmaceuticalsCompletedAttention Deficit/Hyperactivity DisorderUnited States, Germany, Singapore, Colombia, Sweden, Belgium, South Africa, Denmark, Norway
-
North Essex Partnership NHS Foundation TrustUniversity College, London; Hertfordshire Community NHS TrustUnknownAttention Deficit/Hyperactivity DisorderUnited Kingdom
-
CoMentisCompletedAttention Deficit Hyperactivity DisorderUnited States
-
Medical University of South CarolinaNational Institute on Drug Abuse (NIDA)CompletedMarijuana Abuse | Attention Deficit Disorder With HyperactivityUnited States
-
Eli Lilly and CompanyCompletedAttention Deficit Hyperactivity DisorderUnited States, Canada, Puerto Rico
-
Eli Lilly and CompanyCompletedAttention Deficit Hyperactivity Disorder | DyslexiaUnited States
-
University of WyomingRecruitingAttention Deficit Hyperactivity Disorder | Mood | Working Memory | Stimulant Use | Change in Sustained AttentionUnited States
-
Janssen Research & Development, LLCCompletedAttention Deficit Disorder With HyperactivityUnited States
-
SunovionCompletedAdult Attention Deficit Hyperactivity DisorderUnited States
-
Janssen-Cilag International NVCompletedAttention Deficit/ Hyperactivity DisorderFrance, Belgium, Germany, Spain, Switzerland, Denmark, Finland, Netherlands, Norway, Sweden, United Kingdom
-
New York State Psychiatric InstituteNational Institute on Drug Abuse (NIDA)CompletedAttention-deficit/Hyperactivity Disorder | Cannabis Use DisorderUnited States
-
Thomas W. Frazier, Ph.DIntegraGen SACompletedAutism Spectrum Disorder | Attention Deficit/Hyperactivity Disorder | Developmental DelayUnited States
-
Eli Lilly and CompanyTerminatedAttention Deficit Hyperactivity DisorderUnited States, Canada, Taiwan, Puerto Rico
-
AbbVie (prior sponsor, Abbott)CompletedAttention-Deficit/Hyperactivity DisorderUnited States
-
Ironshore Pharmaceuticals and Development, IncCompletedAttention Deficit Hyperactivity DisorderUnited States
-
Novartis PharmaceuticalsCompletedAttention Deficit Hyperactivity DisorderUnited States
-
SunovionCompleted
-
Eli Lilly and CompanyCompletedAttention Deficit Hyperactivity DisorderAustralia, United Kingdom, Mexico
-
Matthew J O'Brien, PhD, BCBA-DRecruitingProblem Behavior | Attention Deficit Hyperactivity DisorderUnited States
-
Lauren KenworthyUniversity of Colorado, Denver; Georgetown UniversityCompletedAutism Spectrum Disorder | Executive Function | Attention Deficit-Hyperactivity DisorderUnited States
-
Eli Lilly and CompanyCompletedAttention Deficit Hyperactivity DisorderUnited States, Puerto Rico
-
Noven TherapeuticsCompletedAttention Deficit Hyperactivity DisorderUnited States
-
New York State Psychiatric InstituteNational Institute on Drug Abuse (NIDA)CompletedCocaine Dependence | Adult Attention Deficit Hyperactivity DisorderUnited States
-
H. Lundbeck A/SCompletedAttention Deficit Hyperactivity DisorderUnited States
-
Supernus Pharmaceuticals, Inc.Active, not recruitingAttention-Deficit/Hyperactivity DisorderUnited States
-
SunovionCompletedAdult Attention Deficit Hyperactivity DisorderUnited States
-
Otsuka Pharmaceutical Development & Commercialization...CompletedAttention Deficit Hyperactivity DisorderUnited States
-
Otsuka Pharmaceutical Development & Commercialization...CompletedAdult Attention Deficit Hyperactivity DisorderUnited States
-
ShireCompletedAttention Deficit Hyperactivity DisorderSpain, United States, Germany, Poland, Italy, Ukraine, Romania, United Kingdom, Sweden, Austria, Canada, France, Ireland
-
Eli Lilly and CompanyCompletedAttention Deficit Hyperactivity DisorderUnited States, Puerto Rico
-
AbbVie (prior sponsor, Abbott)CompletedAttention-Deficit/Hyperactivity DisorderUnited States
-
University of Texas at AustinRecruitingAttention Deficit Hyperactivity Disorder | Cognitive Deficit | Wellness | Attention Difficulties | Attention DeficitUnited States
-
University of Maryland, College ParkNational Institute of Mental Health (NIMH)CompletedDepressive Symptoms | Attention Deficit Hyperactivity DisorderUnited States
-
University of California, San DiegoRady Children's Hospital, San DiegoRecruitingOverweight and Obesity | Attention-Deficit Hyperactivity DisorderUnited States
-
New York State Psychiatric InstituteNational Institute on Drug Abuse (NIDA)CompletedCocaine-Related Disorders | Attention Deficit Disorder With HyperactivityUnited States
-
National Institute of Mental Health (NIMH)WithdrawnAttention Deficit Hyperactivity Disorder | Normal Physiology | Disruptive Mood Dysregulation DisorderUnited States
-
University of HuddersfieldCompletedAttention Deficit Hyperactivity DisorderUnited Kingdom